VEGFA and glioblastoma: circSMARCA5 is an upstream regulator of pro- to antiangiogenic VEGFA alternative splicing isoform ratio within GBM cells, and a highly promising GBM prognostic and prospective antiangiogenic molecule could be a prognostic biomarker and a therapeutic target [23].